- Advised a publicly traded supplier of water and water dispensers in an agreement to acquire by merger a publicly traded competitor for more than $260 million in cash and stock.
- Represented a venture-capital-funded genome editing company in a worldwide partnership, worth up to $1.6 billion.
- Counseled an NYSE-listed energy company in a strategic alliance with an on-site power generation systems company to integrate an energy platform with smart storage solutions, including an initial 50-megawatt project involving distributed generation systems at more than 150 sites.
- Represented an international health care group and U.S. subsidiary in obtaining multinational license rights to three cardiovascular drugs from a public pharmaceutical company for more than $260 million in cash and up to $480 million in milestone and royalty payments.
- Advised an international drug development services organization in the acquisitions of multiple pharmaceutical contract development and manufacturing organizations.
- Represented a global solid-state LED lighting and semiconductor manufacturing company in a Hong Kong joint venture to sell mid-power lighting class LED packaged products.
- Advised public companies in various industries on public disclosure and securities law compliance matters, listing requirements, corporate governance, and general corporate matters.
- Counseled public and private clients on technology contracting, licensing, and other commercial transactions.
Associate,
- Phone: 704.444.1411
- Email: daniel.rowe@alston.com
Dan draws on his transactional experience across multiple industries, including technology, health care, and energy, to efficiently serve the needs of his clients and close the deal.